Study of Hepalatide in Chronic Hepatitis D(CHD) Patients

Clinical trial NCT05827146 · COMPLETED

Trial details

NCT number: NCT05827146
Sponsor: Shanghai HEP Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis D Infection

Start date: 2023-10-07
Primary completion: 2024-01-30
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.